5-Aminolevulinic Acid-Guided Resection in Grade III Tumors-A Comparative Cohort Study.

Operative neurosurgery (Hagerstown, Md.)(2022)

Cited 2|Views2
No score
Abstract
Despite the benefits of 5-ALA in grade IV glioma surgery, these benefits are limited to a smaller group of patients with grade III tumors where there is sufficient fluorescence to allow GTR. In this cohort of patients, 5-ALA use may result in worse neurological outcomes particularly when GTR is not feasible and therefore caution is warranted.
More
Translated text
Key words
5-Aminolevulinic acid,Grade III glioma,Fluorescence-guided surgery,Anaplastic astrocytoma,Resection
AI Read Science
Must-Reading Tree
Example
Generate MRT to find the research sequence of this paper
Chat Paper
Summary is being generated by the instructions you defined